Korean J Nephrol.  2007 May;26(3):334-341.

The Stability of Peritoneal Dialysis for the Treatment of Chronic Renal Failure in Cirrhotic Patients Acompanying Ascites

• Kim JI
• Lee JE
• Baek HJ
• Choi SC
• Do JH
• Huh W
• Kim YG
• Kim DJ
• Oh HY

Abstract

PURPOSE: When liver cirrhosis patients accompanying ascites need renal replacement therapy because of chronic renal failure (CRF), peritoneal dialysis (PD) can allow direct removal of ascites and prevent anticoagulants use. However, since PD might aggravate hypoalbuminemia and increase chances of peritonitis, clinicians tend to hesitate to apply it to those patients. The aim of the present study is to assess the outcome and stability of PD for the treatment of CRF patient with cirrhosis acompanying ascites.
METHODS
A retrospective study based on the clinical records was performed in cirrhotic patients with ascites in whom PD was performed for the treatment of CRF and who were followed up at Samsung Medical Center unit, between January 1995 and July 2005.
RESULTS
In our study, 15 patients were enrolled. Child-pugh class was worse in non-survival group than survival group (p<0.01). One-year patient survival was 40% in Class C and 75% in Class B, and patient survival differed between Class C and Class B (p=0.0014). Causes of death were terminal liver failure (n=6) and sepsis due to pneumonia (n=1). Total 27 episodes of peritonitis occurred, and the peritonitis rates were 0.91 episodes/patients-year.
CONCLUSION
Although the peritonitis rates turned out somewhat high, the use of PD for the treatment of CRF in patients with liver cirrhosis accompanying ascites seems to be safe and effective. Main cause of death in our study seems to be related to liver disease.

Keyword

Peritoneal dialysis (PD); Chronic renal failure (CRF); Liver cirrhosis; Ascites

MeSH Terms

Anticoagulants
Ascites*
Cause of Death
Fibrosis
Humans
Hypoalbuminemia
Kidney Failure, Chronic*
Liver Cirrhosis
Liver Diseases
Liver Failure
Peritoneal Dialysis*
Peritonitis
Pneumonia
Renal Replacement Therapy
Retrospective Studies
Sepsis
Anticoagulants